Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02841956 · ClinicalTrials.gov registry record · NA
Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement
A NA study, sponsored by University of California, Davis.
- Terminated
- Registry status
- NA
- Development phase
- 427
- Enrollment target
NCT02841956 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 427 participants.
The verdict
NCT02841956, a NA study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- NA
- Development phase
- 427 participants
- Enrollment target
Study Summary
Reducing Duration of Untreated Psychosis (DUP) is a primary goal for improving long-term outcomes in young people with a first episode of psychosis (FEP). The "standard of FEP care" within the US focuses on targeted provider education regarding signs and symptoms of early psychosis to motivate patient referrals to FEP services, followed by initiation of services within largely clinic-based settings Experience at the Early Diagnosis and Preventive Treatment (EDAPT) FEP specialty program at U.C. Davis in Sacramento has identified two important bottlenecks to reducing DUP, consistent with reports in the literature from other FEP clinics. These are 1) delays in the identification of psychotic symptoms by referral sources, and 2) delays or disruptions of patient engagement in specialty FEP care. Building upon a comprehensive and established referral network of 20 sites across the Sacramento area (schools/universities, ER/inpatient hospitals, outpatient mental health, primary care), the investigators will address delays in patient identification and engagement using a two-phase, cluster randomized design. The investigators will consecutively test the impact of two interventions to reduce DUP, defined in this RFA as time from first onset of psychotic symptoms to engagement in FEP specialty care. To address identification delays, the investigators will examine the use of standard targeted provider education plus novel technology-enhanced screening compared to standard targeted provider education alone, testing the hypothesis that the education plus technology-enhanced screening will identify more patients, earlier in their illness. To address engagement delays, the investigators will compare the use of a mobile community-based, telepsychiatry-enhanced engagement team to standard clinic-based procedures for intake, engagement and initiation of treatment, to test the hypothesis that the mobile approach facilitates earlier and more stable engagement, thereby reducing DUP. The
Interventions
- OTHER Electronic Screen + Education (Phase 1)
- OTHER Targeted Provider Education (Phase 1)
- OTHER Community Mobile Engagement (Phase 2)
- OTHER Clinic based Engagement (Phase 2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 427 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02841956
The ClinicalTrials.gov registry entry for NCT02841956 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 427 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Electronic Screen + Education (Phase 1) is the first listed.
NCT02841956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02841956 about?
NCT02841956 is a clinical study titled "Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement". Reducing Duration of Untreated Psychosis (DUP) is a primary goal for improving long-term outcomes in young people with a first episode of psychosis (FEP). The "standard of FEP care" within the US focuses on targeted provider education regarding signs and symptoms of early psychosis to motivate patie...
What is the current status of trial NCT02841956?
This trial is currently terminated. It is a NA study. The enrollment target is 427 participants. The study started on 2014-09. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT02841956?
The interventions under investigation include: Electronic Screen + Education (Phase 1) (OTHER), Targeted Provider Education (Phase 1) (OTHER), Community Mobile Engagement (Phase 2) (OTHER), Clinic based Engagement (Phase 2) (OTHER).
Who is sponsoring clinical trial NCT02841956?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.